Defining Abnormal Prostate Specific Antigen Values for Prostate Cancer Screening in the Spinal Cord Injury Population
Uro-Oncology
Related content
COMMENTED
Uro-Oncology
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Benign Prostatic Hyperplasia (BPH)
Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
Prostate
Jirásko M, Viták R, Pecen L, Pinkeová A, Tkáč J, Bertók T, Bergman N, Kučera R
doi: 10.1002/pros.24801
Uro-Oncology
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
BJU Int
Bancroft EK, Page EC, Brook MN, Pope J, Thomas S, Myhill K, Helfand BT, Talaty P, Ong KR, Douglas E, Cook J, Rosario DJ, Salinas M, Buys SS, Anson J, Davidson R, Longmuir M, Side L, Eccles DM, Tischkowitz M, Taylor A, Cruellas M, Ballestero EP, Cleaver R, Varughese M, Barwell J, LeButt M, Greenhalgh L, Hart R, Azzabi A, Jobson I, Cogley L, Evans DG, Rothwell J, Taylor N, Hogben M, Saya S, IMPACT Study Steering Committee; IMPACT Collaborators, Eeles RA, Aaronson NK
doi: 10.1111/bju.16432
Uro-Oncology
Magnetic Resonance Imaging-based Biopsy Strategies in Prostate Cancer Screening: A Systematic Review
Eur Urol
Schoots IG, Ahmed HU, Albers P, Asbach P, van den Bergh RCN, Godtman RA, van Leeuwen PJ, Nordström T, Punwani S, Wallström J, Padhani AR
doi: 10.1016/j.eururo.2025.05.038
Further Publications Urology
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
BJU Int
Merseburger AS, Agarwal N, Bjartell A, Uemura H, Soto AJ, Bhaumik A, Böhm J, Tran N, Krochmann N, Nematian-Samani M, Mundle SD, Brookman-May SD, Lopez-Gitlitz A, McCarthy SA, Chi K, Chowdhury S
doi: 10.1111/bju.16449
Further Publications Urology
Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
Prostate
Bâcle C, Mazancourt ES, Abid N, Ruffion A, Rouvière O, Colombel M, Fassi-Fehri H
doi: 10.1002/pros.24906
Uro-Oncology
Outcome of Subsequent Therapies After (177)Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Prostate
Losee M, Kavanaugh M, Liu M, Borges N, Haberman V, Ritzer J, Wolanski A, Bhimaniya S, Choudhury AD, Hyun H, Stoltenberg H, Kilbridge KL, Morgans A, Pomerantz M, Robertson M, Sakellis C, Shah H, Taplin ME, Wei XX, Ng T, Ravi P, Jacene H
doi: 10.1002/pros.24880
Uro-Oncology
The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy-naive patients, according to the localization of the lesion at the mpMRI: A single-center retrospective observational study
Prostate
Massanova M, Barone B, Caputo VF, Napolitano L, Ponsiglione A, Del Giudice F, Ferro M, Lucarelli G, Lasorsa F, Busetto GM, Robertson S, Trama F, Imbimbo C, Crocetto F
doi: 10.1002/pros.24761
Uro-OncologyFurther Publications Urology
Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era
Prostate Cancer Prostatic Dis
Li EV, Busza AM, Siddiqui MR, Aguiar JA, Keeter MK, Neill C, Kumar SK, Mi X, Schaeffer EM, Patel HD, Ross AE
doi: 10.1038/s41391-024-00853-9